Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 100學年度
  5. 利用幾丁聚醣與玻尿酸形成的奈米粒子作為Docetaxel載體的製備與特性研究
 
  • Details
Options

利用幾丁聚醣與玻尿酸形成的奈米粒子作為Docetaxel載體的製備與特性研究

Other Title
Preparation and Characterization of Docetaxel-loaded Nanoparticles Composed of Chitosan/Hyaluronic Acid
Type
thesis
Date Issued
2012-07-27
Author(s)
林芝蕙
Advisor
許明照
Subjects
系所名稱:藥學研究所
Publisher
藥學研究所
Description
學位別:碩士
語文別:中文
指導教授:許明照
共同指導教授:
口試委員:何秀娥;林山陽;蔡義弘;蔡翠敏
中文關鍵字:奈米粒子;玻尿酸;幾丁聚醣;共聚法
Abstract
大部分的抗癌藥物為疏水性化合物,進入人體後因吸收不佳而易被體內的內皮網狀系統辨識而被快速清除,且因無法精準地到達腫瘤處,故需的提高使用劑量,但因此衍生許多副作用。本研究利用奈米載體系統來乘載藥物,因其粒子顆粒較小,可避免被內皮網狀系統辨識清除,因此能夠在腫瘤細胞中存留較久時間進而達到較好的治療效果並減低副作用。
本研究利用低分子量幾丁聚醣(Chitosan)和低分子量玻尿酸(Hyaluronic acid)形成一簡單的離子性複合體來開發一種新型的奈米粒子系統,透過兩者成分之相對比率不同以調控顆粒大小和界面電位。而後利用共聚法(Coacervation)將難溶性藥物多西紫杉醇(Docetaxel)包覆在奈米粒子中,以達到承載抗癌藥物並安全地增強抗癌藥物的遞送之目的。
由此本研究先取得幾丁聚醣與玻尿酸反應後得最適宜的奈米粒子大小組別,再利用其中三個組別,分別是幾丁聚醣與玻尿酸charge ratio比為7.13、3.58和0.45這三種所形成的奈米粒子來承載包覆多西紫杉醇。製成的多西紫杉醇高分子聚合物奈米粒子粒徑大小在110~840.9nm之間,界面電位在-36 ~ +8.32之間,而藥物包覆率最高能夠達到92.76%,在穿透式電子顯微鏡中也可觀察到所形成的奈米粒子確實是圓形的小顆粒。顯示出利用這種製成確實能夠將難溶性藥物包覆住並且形成奈米粒子,而未來我們還會繼續完成藥物釋放與後續的體外體內試驗,來完成抗癌藥物高分子聚合物奈米輸送載體的開發。
URI
https://203.71.86.71/handle/123456789/11194

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback